Non Substitutive Strategies to Improve Haemophilia Care in Developing Countries. Experience in Ivory Coast.
NCT ID: NCT03054662
Last Updated: 2019-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
142 participants
INTERVENTIONAL
2017-01-16
2019-09-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of Prophylaxis With Emicizumab in Children With Severe Hemophilia A in Ivory Coast
NCT05279924
A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment
NCT02476942
Patient Functioning and Well-being, Economic, and Clinical Impact of Hemophilia A and Its Treatment
NCT02396862
Global Haemostatic Methods Following Administration of Bypassing Agents to Patients With Haemophilia With Inhibitors
NCT02453542
Retrospective Study in Chinese Pediatric Hemophilia A Patients With rFⅧ Contained Regular Prophylaxis
NCT02263066
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Develop tools to assess the intervention (eg transcultural validation of QoL questionnaires, develop booklets to record bleedings...). (year 1)
3. Intervention phase that will focus on education of patients and their family, education of caregivers, training of the laboratory to the diagnosis of haemophilia and promotion of non substitutive strategies to improve haemophilia care in Ivory Coast (DDAVP, antifibrinolytics, physiotherapy, dental care,...).
4. Follow-up phase during 2 years.
5. Outcome analysis
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with Haemophilia
Male patients with severe and moderate haemophilia A and B in Ivory Coast
Education
Education of patients and caregivers about haemophilia and carriers of haemophilia.
Improve biological diagnosis and follow-up of haemophilia
train the laboratory to the diagnosis ans follow-up un haemophilia
Implement haemostatic non substitutive care of haemophilia
Implement the use of DDAVP and antifibrinolytics in patients with haemophilia and symptomatic carriers
Implement non haemostatic care of haemophilia
Implement regular physiotherapy, develop dental care, promote the regular use of pain killers
Carriers for Haemophilia
Carriers for severe and moderate haemophilia A and B in Ivory Coast
Education
Education of patients and caregivers about haemophilia and carriers of haemophilia.
Improve biological diagnosis and follow-up of haemophilia
train the laboratory to the diagnosis ans follow-up un haemophilia
Implement haemostatic non substitutive care of haemophilia
Implement the use of DDAVP and antifibrinolytics in patients with haemophilia and symptomatic carriers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Education
Education of patients and caregivers about haemophilia and carriers of haemophilia.
Improve biological diagnosis and follow-up of haemophilia
train the laboratory to the diagnosis ans follow-up un haemophilia
Implement haemostatic non substitutive care of haemophilia
Implement the use of DDAVP and antifibrinolytics in patients with haemophilia and symptomatic carriers
Implement non haemostatic care of haemophilia
Implement regular physiotherapy, develop dental care, promote the regular use of pain killers
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Females over 12 years who are carriers for severe and moderate haemophilia A and B in Ivory Coast.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
World Federation of Hemophilia
OTHER
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine M Lambert, MD
Role: STUDY_DIRECTOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Yopougon
Abidjan, , Côte d’Ivoire
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002/MSHP/CNER-kp
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.